The DNA index as a prognostic tool in hilar cholangiocarcinoma

Area of Science:

• Oncology
• Surgical Pathology
• Molecular Diagnostics

Background:

• Hilar cholangiocarcinoma (HCCA) has a poor prognosis, necessitating reliable prognostic factors for personalized treatment.
• Current prognostic tools for HCCA are limited, highlighting the need for novel predictive markers.
• Accurate prognostication is crucial for guiding treatment strategies and improving patient outcomes in HCCA.

Purpose of the Study:

• To evaluate the predictive value of the DNA index as a prognostic marker in patients with resected HCCA.
• To compare the prognostic significance of the DNA index against standard histopathological parameters.
• To determine the independence of the DNA index as a predictor of survival in HCCA.

Main Methods:

• A prospective study included 154 patients who underwent resection for HCCA.
• DNA index was measured using image cytometry on fresh tumor samples.
• Survival analysis, including Cox proportional hazards modeling, was performed correlating DNA index and histopathological factors with patient survival.

Main Results:

• The median DNA index was 1.61 ± 0.32.
• Univariate analysis identified the DNA index as a significant prognostic marker, unlike DNA ploidy.
• Multivariate analysis confirmed the DNA index, tumor size, and lymph node status as independent predictors of patient survival.

Conclusions:

• The DNA index is a robust independent prognostic marker for HCCA, outperforming many standard histopathological factors.
• The DNA index's potential for both pre- and postoperative assessment makes it a valuable tool for preoperative decision-making.
• Integrating the DNA index into clinical practice may enhance personalized treatment strategies for HCCA patients.